Downgrades Outperform Mkt Perform X

TXG 10x Genomics

Leerink Partners

$25 $12

Initiated Outperform X

TXG 10x Genomics

Leerink Partners

$35

Upgrades Hold Buy X

TXG 10x Genomics

Jefferies

$24

Downgrades Overweight Neutral X

TXG 10x Genomics

JP Morgan

$40 $20

Downgrades Buy Hold X

TXG 10x Genomics

Deutsche Bank

$55 $25

Downgrades Outperform Peer Perform X

TXG 10x Genomics

Wolfe Research

Downgrades Buy Neutral X

TXG 10x Genomics

Guggenheim

Resumed Hold X

TXG 10x Genomics

Jefferies

$24

Downgrades Buy Hold X

TXG 10x Genomics

TD Cowen

$57 $32

Initiated Buy X

TXG 10x Genomics

Guggenheim

$60

Initiated Outperform X

TXG 10x Genomics

Wolfe Research

$55

Upgrades Underperform Neutral X

TXG 10x Genomics

BofA Securities

$36 $54

Resumed Overweight X

TXG 10x Genomics

JP Morgan

$65

Initiated Overweight X

TXG 10x Genomics

Barclays

$65

Initiated Overweight X

TXG 10x Genomics

Stephens

$65

Initiated Neutral X

TXG 10x Genomics

UBS

$50

Initiated Buy X

TXG 10x Genomics

Deutsche Bank

$50

Downgrades Neutral Sell X

TXG 10x Genomics

Goldman

$55 $35

Initiated Buy X

TXG 10x Genomics

Canaccord Genuity

$55

Downgrades Neutral Underperform X

TXG 10x Genomics

BofA Securities

$35

Downgrades Outperform Mkt Perform X

TXG 10x Genomics

William Blair

Resumed Outperform X

TXG 10x Genomics

Cowen

$205

Initiated Outperform X

TXG 10x Genomics

William Blair

TXG  10x Genomics Inc

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.